Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.19028 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.16555 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.16794 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.11209 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.10775 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.2199 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.18045 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.13885 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.12962 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.15315 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.14749 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.13208 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.17589 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.15604 | 7 |